(Total Views: 673)
Posted On: 09/02/2020 7:16:11 PM
Post# of 148908
Here is the quote from the PR
“Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “We are very encouraged by the MHRA’s considering fast track approval of leronlimab and granting us a meeting. In this meeting, CytoDyn will present a summary of its BLA for HIV in conjunction with our request for fast track approval for COVID-19 indication. We are also grateful to the MHRA for advising us about potential financial support from the sites and UK government for our CD12 study currently in process.”
I don’t know what to take from the above quote. Here is our BLA for HIV app and request for COVID approval. Will you grant us approval right now? Or give us funding to help your U.K. sites to enroll more people in our 12 trial? Or maybe both?
“Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “We are very encouraged by the MHRA’s considering fast track approval of leronlimab and granting us a meeting. In this meeting, CytoDyn will present a summary of its BLA for HIV in conjunction with our request for fast track approval for COVID-19 indication. We are also grateful to the MHRA for advising us about potential financial support from the sites and UK government for our CD12 study currently in process.”
I don’t know what to take from the above quote. Here is our BLA for HIV app and request for COVID approval. Will you grant us approval right now? Or give us funding to help your U.K. sites to enroll more people in our 12 trial? Or maybe both?
(1)
(0)Scroll down for more posts ▼
